Market Overview

Valent BioSciences Unveils New Biorational Research Center


Grand Opening event attracts attendees from around the world to
tour high tech facility

Valent BioSciences (VBC) officially opened the doors of its new global
research facility, the Biorational Research Center (BRC), at a July 24th
gala at Libertyville's stylish Innovation Park. More than 250 guests,
ranging from the Deputy Governor of the State of Illinois, to strategic
partners, customers, allied industry representatives, and leading
members of the scientific community gathered to join Grand Opening
festivities and tour the 85,000 square-foot facility adjacent to the
company's long-time headquarters.

The opening of the BRC completes a two-year build-out and transition
from VBC's legacy research facility in nearby Long Grove, IL. The
facility boasts approximately 65,000 square-feet of open-concept lab and
office space combined with a state-of-the-art, 20,000 square-foot
greenhouse. In addition to its technological upgrades, the move is
intended to streamline cross-functional collaboration among VBC's
industry-leading team of innovative plant, soil, and formulation
scientists, microbiologists, entomologists, and chemists – a team that
brings best-in-class solutions to agriculture, public health, and forest
health professionals around the world.

"This breathtaking new facility is a testimony to the notable success of
our R&D group," said Ted Melnik, Executive Vice President and Chief
Operating Officer of VBC. "All patents and awards aside, that success
ultimately comes down to an ability to develop and commercialize
sustainable products that deliver clear value to our stakeholders –
whether they be growers, food companies, foresters, or governments that
fight against insect-borne disease."

The BRC is the latest addition to the Sumitomo Chemical Company (SCC)
Biorational Research Network (BRN), a strategic enterprise that includes
both internal resources and external (3rd party) expertise.
As the parent company to VBC, SCC deploys a global team of scientists
operating in lab and field research facilities at key locations around
the globe. Central to the BRN mission are investigations that brings
together biorational and conventional technologies that work in harmony
with nature.

The opening of the BRC is another in a string of investments VBC has
made into its burgeoning biorational business over recent years. In
addition to the acquisition of Pace International (2012) and Mycorrhizal
Applications (2015), VBC also opened its Iowa-based $150 million
biorational manufacturing plant in 2014, the first ever purpose-built
biorational facility in the world.

About Valent BioSciences

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of
Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the
development, manufacturing and commercialization of biorational products
with sales in 95 countries around the world. Valent BioSciences is an
ISO 9001:2008 Certified Company. For additional information, visit the
company's website at

View Comments and Join the Discussion!